Accelerated development of polyoma tumors and embryonic lethality: Different effects of p53 loss on related mouse backgrounds

Cell Growth and Differentiation

Volumn 11, Issue 5, 2000, Pages 231-237

  Dey, Dilip C ^a   Bronson, Roderick P ^a   Dahl, Jean ^a   Carroll, John P ^a   Benjamin, Thomas L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEIN P21; PROTEIN P53;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; EMBRYO; GENE INACTIVATION; GENE LOSS; GENETIC SUSCEPTIBILITY; KNOCKOUT MOUSE; LETHALITY; NEWBORN; NONHUMAN; POLYOMA VIRUS; PRIORITY JOURNAL; PROTEIN INDUCTION; STRAIN DIFFERENCE; TUMOR SUPPRESSOR GENE; VIRUS CARCINOGENESIS;

ANIMALS; ANIMALS, NEWBORN; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; FETAL DEATH; GENE EXPRESSION; MICE; MICE, INBRED AKR; MICE, INBRED CBA; MICE, KNOCKOUT; PAPILLOMAVIRUS INFECTIONS; POLYOMAVIRUS; SPECIES SPECIFICITY; TUMOR SUPPRESSOR PROTEIN P53; TUMOR VIRUS INFECTIONS;

ANIMALIA; DNA VIRUSES; PAPOVAVIRIDAE; POLYOMAVIRUS; RODENTIA; TUMOR VIRUS;

EID: 0034036350     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Bauer, P. H., Bronson, R. T., Fung, S. C., Freund, R., Stehle, T., Harrison, S. C., and Benjamin, T. L. Genetic and structural analysis of a virulence determinant in polyomavirus VP1. J. Virol., 69: 7925-7931, 1995.
2. Chen, H. M., and Benjamin, T. L. Roles of N-glycans with α2,6 as well as α2,3 linked sialic acid in infection by polyoma virus. Virology, 233: 440-442, 1997.
3. Cole, C. Polyomaviridae: the viruses and their replication. In: B. Fields, D. Knipe, and P. Howley (eds.), Fields Virology, Ed. 3, Vol. 2, pp. 1997-2025. Philadelphia: Lippincott-Raven, 1996.
4. Nevins, J., and Vogt, P. Cell transformation by viruses. In: B. Fields, D. Knipe, and P. Howley (eds.), Fields Virology, Ed. 3, Vol. 1, pp. 301-343. Philadelphia: Lippincott-Raven, 1996.
5. Howley, P. M., Ganem, D., and Kieff, E. Etiology of cancer: section 2. DNA viruses. In: V. T. De Vita, S. Hellman, S., and S. A. Rosenberg (eds). Cancer: Principles and Practice of Oncology, Ed. 5. Philadelphia: Lippincott-Raven, 1997.
6. Doherty, J., and Freund, R. Middle T antigen activation of signal transduction pathways does not overcome p53-mediated growth arrest. J. Virol., 73: 7882-7885, 1999.
7. Freund, R., Bauer, P. H., Crissman, H. A., Bradbury, E. M., and Benjamin, T. L. Host range and cell cycle activation properties of polyomavirus large T-antigen mutants defective in pRB binding. J. Virol., 68: 7227-7234, 1994.
8. Mor, O., Read, M., and Fried, M. p53 in polyoma virus transformed REF52 cells. Oncogene, 15: 3113-3119, 1997.
9. Doherty, J., and Freund, R. Polyomavirus large T antigen overcomes p53 dependent growth arrest. Oncogene, 14: 1923-1931, 1997.
10. Reihsaus, E., Kraiss, S., Barnekow, A., and Montenarh, M. Cooperation of p53 and polyoma virus middle T antigen in the transformation of primary rat embryo fibroblasts. Exp. Cell Res., 199: 10-18, 1992.
11. Qian, W., Kashuba, E., Magnusson, K. P., Pokrovskaja, K., Okan, I., Klein, G., and Wiman, K. G. Role of p53 mutation in polyomavirus-induced tumorigenesis. J. Gen. Virol., 78: 893-903, 1997.
12. Wang, E. H., Friedman, P. N., and Prives, C. The murine p53 protein blocks replication of SV40 DNA in vitro by inhibiting the initiation functions of SV40 large T antigen. Cell, 57: 379-392, 1989.
13. Freedman, D. A., Wu, L., and Levine, A. J. Functions of the MDM2 oncoprotein. Cell. Mol. Life Sci., 55: 96-107, 1999.
14. Honda, R., and Yasuda, H. Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53. EMBO J., 18: 22-27, 1999.
15. Hupp, T. R. Regulation of p53 protein function through alterations in protein-folding pathways. Cell. Mol. Life Sci., 55: 88-95, 1999.
16. Jayaraman, L., and Prives, C. Covalent and noncovalent modifiers of the p53 protein. Cell. Mol. Life Sci., 55: 76-87, 1999.
17. Waterman, M. J., Stavridi, E. S., Waterman, J. L., and Halazonetis, T. D. ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins. Nat. Genet., 19: 175-178, 1998.
18. Weber, J. D., Taylor, L. J., Roussel, M. F., Sherr, C. J., and Bar-Sagi, D. Nucleolar Arf sequesters Mdm2 and activates p53. Nat. Cell Biol., 1: 20-26, 1999.
19. Midgley, C. A., Owens, B., Briscoe, C. V., Thomas, D. B., Lane, D. P., and Hall, P. A. Coupling between gamma irradiation, p53 induction and the apoptotic response depends upon cell type in vivo. J. Cell Sci., 108: 1843-1848, 1995.
20. Attardi, L. D., and Jacks, T. The role of p53 in tumour suppression: lessons from mouse models. Cell. Mol. Life Sci., 55: 48-63, 1999.
21. Lavigueur, A., and Bernstein, A. p53 transgenic mice: accelerated erythroleukemia induction by Friend virus. Oncogene, 12: 2197-2201, 1991.
22. Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Jr., Butel, J. S., and Bradley, A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature (Lond.), 356: 215-221, 1992.
23. Jacks, T., Remington, L., Williams, B. O., Schmitt, E. M., Halachmi, S., Bronson, R. T., and Weinberg, R. A. Tumor spectrum analysis in p53-mutant mice. Curr. Biol., 4: 1-7, 1994.
24. Freund, R., Dubensky, T., Bronson, R., Sotnikov, A., Carroll, J., and Benjamin, T. Polyoma tumorigenesis in mice: evidence for dominant resistance and dominant susceptibility genes of the host. Virology, 191: 724-731, 1992.
25. Lukacher, A. E., Ma, Y., Carroll, J. P., Abromson-Leeman, S. R., Laning, J. C., Dorf, M. E., and Benjamin, T. L. Susceptibility to tumors induced by polyoma virus is conferred by an endogenous mouse mammary tumor virus superantigen. J. Exp. Med., 181: 1683-1692, 1995.
26. Lukacher, A. E., and Wilson, C. S. Resistance to polyoma virus-induced tumors correlates with CTL recognition of an immunodominant H-2Dk-restricted epitope in the middle T protein. J. Immunol., 160: 1724-1734, 1998.
27. Dawe, C. J., Freund, R., Mandel, G., Ballmer-Hofer, K., Talmage, D. A., and Benjamin, T. L. Variations in polyoma virus genotype in relation to tumor induction in mice. Characterization of wild type strains with widely differing tumor profiles. Am. J. Pathol., 127: 243-261, 1987.
28. Chattopadhyay, S. K., Lowy, D. R., Teich, N. M., Levine, A. S., and Rowe, W. P. Qualitative and quantitative studies of AKR-type murine leukemia virus sequences in mouse DNA. Cold Spring Harbor Symp. Quant. Biol., 39 (Part 2): 1085-101, 1975.
29. Martinez, J., Georgoff, I., and Levine, A. J. Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein. Genes Dev., 5: 151-159, 1991.
30. Janus, F., Albrechtsen, N., Dornreiter, I., Wiesmuller, L., Grosse, F., and Deppert, W. The dual role model for p53 in maintaining genomic integrity. Cell. Mol. Life Sci., 55: 12-27, 1999.
31. Venkatachalam, S., Shi, Y. P., Jones, S. N., Vogel, H., Bradley, A., Pinkel, D., and Donehower, L. A. Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation. EMBO J., 17: 4657-4667, 1998.
32. Herzig, M., Novatchkova, M., and Christofori, G. An unexpected role for p53 in augmenting SV40 large T antigen-mediated tumorigenesis. Biol. Chem., 380: 203-211, 1999.
33. Mudrak, I., Ogris, E., Rotheneder, H., and Wintersberger, E. Coordinated transactivation of DNA synthesis- and precursor-producing enzymes by polyomavirus large T antigen through interaction with the retinoblastoma protein. Mol. Cell. Biol., 14: 1886-1892, 1994.
34. Dahl, J., Jurczak, A., Cheng, L. A., Baker, D. C., and Benjamin, T. L. Evidence of a role for phosphatidylinositol 3-kinase activation in the blocking of apoptosis by polyomavirus middle T antigen. J. Virol., 72: 3221-3226, 1998.
35. Meili, R., Cron, P., Hemmings, B. A., and Ballmer-Hofer, K. Protein kinase B/Akt is activated by polyomavirus middle-T antigen via a phosphatidylinositol 3-kinase-dependent mechanism. Oncogene, 16: 903-907, 1998.
36. Nemethova, M., and Wintersberger, E. Polyomavirus large T antigen binds the transcriptional coactivator protein p300. J. Virol., 73: 1734-1739, 1999.
37. Howard, J. C., Yousefi, S., Cheong, G., Bernstein, A., and Ben-David, Y. Temporal order and functional analysis of mutations within the Fli-1 and p53 genes during the erythroleukemias induced by F-MuLV. Oncogene, 8: 2721-2729, 1993.
38. Harvey, D. M., and Levine, A. J. p53 alteration is a common event in the spontaneous immortalization of primary BALB/c murine embryo fibroblasts. Genes Dev., 5: 2375-2385, 1991.
39. Choi, J., and Donehower, L. A. p53 in embryonic development: maintaining a fine balance. Cell. Mol. Life Sci., 55: 38-47, 1999.
40. Lozano, G., and Liu, G. Mouse models dissect the role of p53 in cancer and development. Semin. Cancer Biol., 8: 337-344, 1998.
41. Armstrong, J. F., Kaufman, M. H., Harrison, D. J., and Clarke, A. R. High-frequency developmental abnormalities in p53-deficient mice. Curr. Biol., 5: 931-936, 1995.
42. Sah, V. P., Attardi, L. D., Mulligan, G. J., Williams, B. O., Bronson, R. T., and Jacks, T. A subset of p53-deficient embryos exhibit exencephaly. Nat. Genet., 10: 175-180, 1995.
43. Schmid, P., Lorenz, A., Hameister, H., and Montenarh, M. Expression of p53 during mouse embryogenesis. Development (Camb.), 113: 857-865, 1991.
44. Komarova, E. A., Chernov, M. V., Franks, R., Wang, K., Armin, G., Zelnick, C. R., Chin, D. M., Bacus, S. S., Stark, G. R., and Gudkov, A. V. Transgenic mice with p53-responsive lacZ: p53 activity varies dramatically during normal development and determines radiation and drug sensitivity in vivo. EMBO J., 16: 1391-1400, 1997.
45. Montes de Oca Luna, R., Wagner, D. S., and Lozano, G. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature (Lond.), 378: 203-206, 1995.
46. Ikeda, S., Hawes, N. L., Chang, B., Avery, C. S., Smith, R. S., and Nishina, P. M. Severe ocular abnormalities in C57BL/6 but not in 129/Sv p53-deficient mice. Investig. Ophthalmol. Vis. Sci., 40: 1874-1878, 1999.
47. Laird, P. W., Zijderveld, A., Linders, K., Rudnicki, M. A., Jaenisch, R., and Berns, A. Simplified mammalian DNA isolation procedure. Nucleic Acids Res., 19: 4293, 1991.
48. Bjelogrlic, N. M., Makinen, M., Stenback, F., and Vahakangas, K. Benzo[a]pyrene-7,8-diol-9,10-epoxide-DNA adducts and increased p53 protein in mouse skin. Carcinogenesis (Lond.), 15: 771-774, 1994.
49. Shi, S. R., Key, M. E., and Kalra, K. L. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J. Histochem. Cytochem., 39: 741-748, 1991.